2020 was heralded as the year the global community stepped up its fight to eradicate malaria once and for all. Slowing death rates and mortality1, coupled with advancements in detection and research, painted an encouraging picture. Now Covid-19 threatens to...
We are proud to have been named as one of the top 100 health and medtech startups for 2020 by HexGn – an international group of investors, based in New Delhi. HexGn’s network of more than 20 000 investors delivers...
The latest version of our quarterly newsletter, A View from the Field, is now available. This issue features a World Malaria Day message from our founder, Dr Benji Pretorius on the need for malaria prevention projects to continue in the...
“We are on a mission to save lives.” Dr Benji Pretorius has a special message from the South Africa-Zimbabwe border for World Malaria Day 2020. As the world tries to cope with the Covid19 pandemic, Dr Pretorius – who himself...
Dr Benji Pretorius urges continued focus on the detection and diagnosis of the disease during the Covid19 pandemic. Dr Pretorius, founder of Erada Technology Alliance, warns that recent progress made in the fight to end malaria will be undone if...
It’s been an exciting year here at Erada. As a Christmas gift, we’re providing the first edition of our new newsletter, which will provide updates of our research each quarter of the year. Take a read and sign up below....
We are heartened by the global progress made with efforts to prevent and treat malaria, and by the commitment made by world leaders and governments to fund those efforts so that we may see a world without malaria within our...
Our ambition to eradicate malaria through developing SALVA!, the world’s first saliva-based rapid diagnostic test has moved a step closer after winning the 2019 Africa Challenge and a 3,000 EUR funding prize. This has also allowed us to book a...
We are proud to be an Africa Challenge Finalist...
The eradication of malaria has been given a boost following a grant of more than £1 Million ($ 1,299,161, ¥ 138,269,665) from Japan’s Global Health Innovative Technology (GHIT) Fund to facilitate the production, testing and validation trials of the world’s...